BioMérieux Reports Sales Increases for Q4, FY15 | GenomeWeb

NEW YORK (GenomeWeb) – BioMérieux today reported organic sales growth of 4 percent for the fourth quarter, with full year 2015 organic sales up 7 percent.

The Marcy L'Etoile, France-based in vitro diagnostics firm said Q4 organic sales growth was slower than previous quarters due to unfavorable prior-year comparatives and a delayed start to the flu season. Sales for the three months ending Dec. 31, 2015 were €553.1 million ($599.6 million), a like-for-like change of 4 percent from €505.7 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.